Globe Life INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Globe Life Inc. announced the retirement of Director David A. Rodriguez from its Board, effective August 4, 2026, for personal reasons.
NYSE
Globe Life Inc. announced robust second quarter 2026 financial results, with net income per diluted share rising 20% and net operating income per diluted share increasing 10% year-over-year, prompting an increase in full-year earnings guidance.
NYSE
Globe Life Inc. has entered into a Third Amended and Restated Credit Agreement and an Amended and Restated Term Loan Agreement, extending maturity dates and increasing loan amounts.
NYSE
Globe Life Inc. reports results from its Annual Meeting of Shareholders, including director elections and advisory votes on executive compensation and incentive plans.
NYSE
Globe Life reported strong Q1 2026 results with a 13% increase in net income per share and raised its full-year 2026 earnings guidance.
NYSE
Globe Life Inc. has expanded its Board of Directors from twelve to fourteen members, appointing Derek T. Kan and Sandra L. Phillips as independent directors.
NYSE
Globe Life Inc. announced robust fourth quarter and full-year 2025 financial results, with net operating income per diluted common share surpassing previous guidance.
NYSE
Globe Life Inc. has amended its Supplemental Executive Retirement Plan, revising early retirement reduction factors and enhancing benefits during a change of control for eligible executives.
NYSE
Globe Life Inc. reported a significant 38% increase in net income and net operating income per diluted common share for the third quarter of 2025, driven by robust underwriting margins and strategic share repurchases.
NYSE
Globe Life Inc. announced the conclusion of both SEC and Department of Justice investigations with no enforcement actions or recommendations.
NYSE
Globe Life Inc. announced robust second quarter 2025 financial results, with net operating income per diluted common share increasing 10% and significant growth in key insurance segments, while reaffirming its full-year earnings guidance.
NYSE
Globe Life Inc. has completed the issuance of $500 million in Pre-Capitalized Trust Securities to secure contingent liquidity for general corporate purposes.
NYSE
Globe Life Inc. announced a strong first quarter in 2025, with net operating income per diluted common share exceeding management's expectations.
NYSE
Globe Life Inc. reports the retirement of a director and the results of its annual shareholder meeting, including the election of directors, approval of executive compensation, and ratification of the independent auditor.
NYSE
Globe Life Inc. has increased its board size from eleven to thirteen members, appointing Matthew J. Adams and Philip M. Jacobs as new independent directors effective February 26, 2025.
NYSE
Globe Life Inc. announces increased net income and net operating income for both the fourth quarter and full year 2024, along with positive growth across key divisions and agent counts.
NYSE
Globe Life Inc. has amended its 8-K filing to provide additional details regarding a data breach that exposed the personal information of approximately 5,000 individuals and has initiated voluntary notifications for an additional 850,000 individuals.
NYSE
Globe Life Inc. has adopted a new executive severance plan and amended its equity award agreements, providing enhanced benefits to eligible executives upon qualifying terminations.
NYSE
Globe Life Inc. will implement a blackout period for its Savings and Investment Plan due to a change in record keepers from Empower Retirement to Fidelity Investments, temporarily suspending certain transactions.
NYSE
Globe Life Inc. announced a significant increase in net income and net operating income per diluted share for the third quarter of 2024, alongside growth in sales and agent numbers across its divisions.
NYSE
Globe Life Inc. is investigating an extortion attempt by an unknown threat actor who claims to possess personal information of approximately 5,000 customers and leads.
NYSE
Globe Life Inc. is facing allegations of sex and race discrimination from the EEOC, which the company disputes, particularly regarding the employment status of its sales agents.
NYSE
Globe Life Inc. has successfully completed the issuance and sale of $450 million in senior notes due in 2034, with the net proceeds intended for general corporate purposes.
NYSE
Globe Life Inc. has amended its term loan agreement, increasing the principal amount to $250 million and extending the maturity date to August 15, 2027.
NYSE
Globe Life Inc. announced a significant increase in net income and net operating income for the second quarter of 2024, driven by strong sales and agent growth across its divisions.
NYSE
Globe Life's Audit Committee concluded its independent investigation, finding no basis for short seller allegations of financial misreporting or insurance fraud.
NYSE
Globe Life Inc. is investigating a potential security breach involving unauthorized access to a web portal, which has been temporarily shut down.
NYSE
Globe Life Inc. has received a preliminary inquiry from the SEC regarding recent short seller reports and intends to cooperate fully.
NYSE
Globe Life Inc. reports the retirement of a board member and the results of shareholder voting at its annual meeting on April 25, 2024.
NYSE
Globe Life Inc. announced a 14% increase in net income and a 6% increase in net operating income for the first quarter of 2024, driven by strong sales and agent growth across its divisions.